Genoskin is a biotech company founded in 2011, located in Boston, MA and Toulouse, France. The company provides ready-to-use, standardized, immunocompetent, and injectable human ex vivo skin assays that are alive and functional for 7 + days. Genoskin has the only living injectable human platform on the market, which enables the accelerated generation of actual human data applicable to all drug development. The technology bridges in vitro and clinical testing, enabling the earlier generation of relevant human data.